Phillip McAllister
Medical · San Antonio, TXNPI 1982107124
Payments from drug & device makers
Across 234 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$818
- GSK$662
- Regeneron Healthcare Solutions, Inc.$477
- CSL Behring$433
- Takeda Pharmaceuticals U.S.A., Inc.$407
- Pfizer$176
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $818 |
| GSK | 45 | $662 |
| Regeneron Healthcare Solutions, Inc. | 19 | $477 |
| CSL Behring | 21 | $433 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $407 |
| Pfizer | 11 | $176 |
| Genentech USA, Inc. | 9 | $164 |
| Octapharma USA, Inc. | 6 | $120 |
| Alk-abello, Inc | 6 | $97 |
| Aytu Biopharma, Inc. | 1 | $96 |
| Kaleo, Inc. | 5 | $95 |
| Boehringer Ingelheim | 5 | $91 |
| Grifols USA, LLC | 5 | $86 |
| Incyte Corporation | 5 | $85 |
| Optinose US, Inc. | 4 | $76 |
| Novartis | 4 | $76 |
| Biocryst US Sales Co., LLC | 4 | $73 |
| Greer Laboratories, Inc. | 3 | $66 |
| Sanofi | 4 | $65 |
| Lilly USA, LLC | 3 | $62 |
| Amgen | 3 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Blueprint Medicines Corporation | 2 | $34 |
| Organon | 2 | $26 |
| AbbVie | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Covis Pharma GmbH | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Phadia US Inc. | 1 | $13 |
How this compares
$4,514 in reported general payments places this provider in the 80th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 113 | $82,578 |
| Dupixent PenDupilumab | 17 | $69,731 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $17,845 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $14,768 |
| Spiriva RespimatTiotropium Bromide | 11 | $6,482 |
| Azelastine Hcl | 140 | $4,628 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $4,103 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $4,049 |
| Arnuity ElliptaFluticasone Furoate | 15 | $2,978 |
| Fluticasone Propionate | 174 | $2,523 |
| Epinephrine | 11 | $2,414 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 19 | $2,290 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,645 |
| Mometasone Furoate | 20 | $1,615 |
| Desloratadine | 42 | $1,459 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $662 | $100,324146 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $818 | $21,89542 claims |
| Boehringer IngelheimSpiriva Respimat | $91 | $6,48211 claims |
| Hikma Pharmaceuticals USAEpinephrine | $15 | $2,41411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,490 medical providers in Texas.
Other medical in San Antonio
- Jose de la CerdaSan Antonio$1.1M
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- John KodoskySan Antonio$58K
- Amanda MillerSan Antonio$27K
- Felipe GalvanSan Antonio$26K
- Ledyenska BallesterosSan Antonio$22K
- Daniella ArellanoSan Antonio$15K
- Robert SchonhoffSan Antonio$14K
- Tanya GainesSan Antonio$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.